Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia
| Autor: | Lasalvia, Pieralessandro, Hernández, Fabián, Castañeda-Cardona, Camilo, Cuestas, J. Andrés, Rosselli, Diego |
|---|---|
| Zdroj: | In Value in Health Regional Issues December 2020 23:13-18 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect